Follow the 켈스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 켈스 has logged 11 public disclosures. The latest transaction was reported on 8 August 2025 (Purchase). Among the most active insiders: 한국투자파트너스. All data is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
켈스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.